Quick Heal Technologies Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
QUICKHEAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Quick Heal Technologies reported weak Q1 FY26 (quarter ended June 30, 2025) results. Consolidated revenue fell 18.6% year-on-year to ₹57.2 crore from ₹70.3 crore in Q1 FY25. The company swung to a loss with EBITDA of ₹(9.7) crore versus a positive ₹2.6 crore last year, and EBITDA margin compressed sharply to -17.0% from 3.7%. Profit after tax (PAT) was ₹(5.5) crore compared to a profit of ₹4.0 crore in Q1 FY25, translating to a diluted EPS of ₹(1.0). The consumer business was the main drag, declining about 27.8% YoY to ₹31.7 crore, while enterprise revenue fell a milder 2.3% to ₹31.7 crore. Management cited consumer headwinds and deferred enterprise deal closures but highlighted international revenue growth of roughly 2x YoY and deferred revenue of ₹16.6 crore.
This is a clearly negative quarter – both revenue and profitability deteriorated sharply, pushing the company into operating losses. Shareholders should expect near-term pressure on the stock given the weak print, though management's commentary on pipeline build-up, new product launches and international expansion may cushion sentiment. Investors should watch for recovery in the consumer segment and stabilization of margins in the coming quarters.